Potentials of curcumin as an antidepressant

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 1233-1241

  Kulkarni, S K ^a   Dhir, Ashish ^a   Akula, Kiran Kumar ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Animal models; Curcumin; Depression; Inflammation; Neurotransmitters; Neurotrophic factors

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CURCUMIN; DESIPRAMINE; FLUOXETINE; NEUROTRANSMITTER; VENLAFAXINE; MONOAMINE OXIDASE INHIBITOR;

BRAIN FUNCTION; CHRONIC FATIGUE SYNDROME; COGNITION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; MAJOR DEPRESSION; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; REVIEW; STRESS; ANIMAL; ANIMAL MODEL; BRAIN; HUMAN; MENTAL STRESS; OLFACTORY BULB; PHYSIOLOGY; SWIMMING;

ANIMALIA;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; CURCUMIN; DEPRESSIVE DISORDER, MAJOR; HUMANS; MODELS, ANIMAL; MONOAMINE OXIDASE INHIBITORS; OLFACTORY BULB; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 73949136192     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.137     Document Type: Review

References (47)

1. Aggarwal, B.B., Sundaram, C., Malani, N., and Ichikawa, H. (2007) Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 595, 1-75.
2. Sreejayan, R. and Rao, M.N. (1994) Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol. 46, 1013-1016.
3. Ammon, H.P. and Wahl, M.A. (1991) Pharmacology of Curcuma longa. Planta Med. 57, 1-7.
4. Brouet, I. and Ohshima, H. (1995) Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun. 206, 533-540.
5. Dikshit, M., Rastogi, L., Shukla, R., and Srimal, R.C. (1995) Prevention of ischaemia-induced biochemical changes by curcumin and quinidine in the cat heart. Indian J. Med. Res. 101, 31-35.
6. Johnson, S.M., Gulhati, P., Arrieta, I., Wang, X., Uchida, T., Gao, T., and Evers, B.M. (2009) Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer Res. 29, 3185-3190.
7. Limtrakul, P., Lipigorngoson, S., Namwong, O., Apisariyakul, A., and Dunn, F.W. (1997) Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett. 116, 197-203.
8. Kiso, Y., Suzuki, Y., Watanabe, N., Oshima, Y., and Hikino, H. (1983) Antihepatotoxic principles of Curcuma longa rhizomes. Planta Med. 49, 185-187.
9. Rao, C.V., Rivenson, A., Simi, B., and Reddy, B.S. (1995) Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55, 259-266.
10. Srinivasan, M. (1972) Effect of curcumin on blood sugar as seen in a diabetic subject. Indian J. Med. Sci. 26, 269-270.
11. Babu, P.S. and Srinivasan, K. (1995) Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol. Cell. Biochem. 152, 13-21.
12. Arun, N. and Nalini, N. (2002) Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum. Nutr. 57, 41-52.
13. Srivastava, R., Dikshit, M., Srimal, R.C., and Dhawan, B.N. (1985) Antithrombotic effect of curcumin. Thromb. Res. 40, 413-417.
14. Deodhar, S.D., Sethi, R., and Srimal, R.C. (1980) Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J. Med. Res. 71, 632-634.
15. Ma, Q.L., Yang, F., Rosario, E.R., Ubeda, O.J., Beech, W., Gant, D.J., Chen, P.P., Hudspeth, B., Chen, C., Zhao, Y., Vinters, H.V., Frautschy, S.A., and Cole, G.M. (2009) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J. Neurosci. 29, 9078-9089.
16. Jagatha, B., Mythri, R.B., Vali, S., and Bharath, M.M. (2008) Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies. Free Radic. Biol. Med. 44, 907-917.
17. Bishnoi, M., Chopra, K., and Kulkarni, S.K. (2008) Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain. Pharmacol. Biochem. Behav. 88, 511-522.
18. Jagota, A. and Reddy, M.Y. (2007) The effect of curcumin on ethanol induced changes in suprachiasmatic nucleus (SCN) and pineal. Cell. Mol. Neurobiol. 27, 997-1006.
19. Riemer, C., Burwinkel, M., Schwarz, A., Gültner, S., Mok, S.W., Heise, I., Holtkamp, N., and Baier, M. (2008) Evaluation of drugs for treatment of prion infections of the central nervous system. J. Gen. Virol. 89, 594-597.
20. Ovbiagele, B. (2008) Potential role of curcumin in stroke prevention. Expert Rev Neurother. 8, 1175-1176.
21. Kumar, A., Dogra, S., and Prakash, A. (2009) Protective effect of curcumin (Curcuma longa), against aluminium toxicity: possible behavioral and biochemical alterations in rats. Behav. Brain Res. 205(2), 384-390.
22. Jyoti, A., Sethi, P., and Sharma, D. (2009) Curcumin protects against electrobehavioral progression of seizures in the iron-induced experimental model of epileptogenesis. Epilepsy Behav. 14, 300-308.
23. Sharma, S., Chopra, K., and Kulkarni, S.K. (2007) Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother. Res. 21, 278-283.
24. Wong, M.L. and Licinio, J. (2001) Research and treatment approaches to depression. Nat. Rev. Neurosci. 2, 343-351.
25. Wong, M.L. and Licinio, J. (2004) From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat. Rev. Drug Discov. 3, 136-151.
26. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, A.J., Walters, E.E., and Wang, P.S. (2003) National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095-4105.
27. Greist, J.H., Mundt, J.C., and Kobak, K. (2002) Factors contributing to failed trials of new agents: can technology prevent some problems? J. Clin. Psychiatry 2, 8-13.
28. Artigas, F., Romero, L., de Montigny, C., and Blier, P. (1996) Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci. 19, 378-383.
29. Ballard, C., Bannister, C., Solis, M., Oyebode, F., and Wilcock, G. (1996) The prevalence, associations and symptoms of depression amongst dementia sufferers. J. Affect. Disord. 36, 135-144.
30. Stepaniuk, J., Ritchi, L., and Tuokko, H.A. (2008) Neuropsychiatric impairments as predictors of mild cognitive impairment, dementia, and Alzheimer's disease. Am. J. Alzheimers Dis .Other Demen. 23, 326-333.
31. Kokmen, E., Beard, C.M., O'Brien, P.C., and Kurland, L.T. (1996) Epidemiology of dementia in Rochester, Minnesota. Mayo Clin. Proc. 71, 275-282.
32. Kulkarni, S.K., Bhutani, M.K., and Bishnoi, M. (2008) Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl.) 201, 435-442.
33. Xu, Y., Ku, B.S., Yao, H.Y., Lin, Y.H., Ma, X., Zhang, Y.H., and Li, X.J. (2005) The effects of curcumin on depressive-like behaviors in mice. Eur. J Pharmacol. 518, 40-46.
34. Xu, Y., Ku, B., Cui, L., Li, X., Barish, P.A., Foster, T.C., and Ogle, W.O. (2007). Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res. 1162, 9-18.
35. Xu, Y., Ku, B., Tie, L., Yao, H., Jiang, W., Ma, X., and Li, X. (2006) Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res. 1122, 56-64.
36. Wang, R., Li, Y.B., Li, Y.H., Xu, Y., Wu, H.L., and Li, X.J. (2008) Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Res. 1210, 84-91.
37. Wong, M.L., Dong, C., Maestre-Mesa, J., and Licinio, J. (2008) Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol. Psychiatry 13, 800-812.
38. Xu, Y.X, Pindolia, K.R., Janakiraman, N., Chapman, R.A., and Gautam, S.C. (1998) Curcumin inhibits IL-1 alpha and TNF-alpha induction of AP-1 and NK-kB DNA-binding activity in bone marrow stromal cells. Hematopathol. Mol. Hematol. 11, 49-62.
39. Chan, M.M., Huang, H.I., Fenton, M.R., and Fong, D. (1998) In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem. Pharmacol. 55, 1955-1962.
40. Lim, G.P., Chu, T., Yang, F., Beech, W., Frautschy, S.A., and Cole, G.M. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 8370-8377.
41. Xu, Y., Ku, B.S., Yao, H.Y., Lin, Y.H., Ma, X., Zhang, Y.H., and Li, X.J. (2005) Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol. Biochem. Behav. 82, 200-206.
42. Wang, R., Xu, Y., Wu, H.L., Li, Y.B., Li, Y.H., Guo, J.B., and Li, X.J. (2008)The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Eur. J. Pharmacol. 578, 43-50.
43. Bhutani, M.K., Bishnoi, M., and Kulkarni, S.K. (2009) Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol. Biochem. Behav. 92, 39-43.
44. Katz, R.J. and Schmaltz, K. (1980) Dopaminergic involvement in attention, a novel animal model. Prog. Neuropsychopharmacol. 4, 585-590.
45. Li, Y.C., Wang, F.M., Pan, Y., Qiang, L.Q., Cheng, G., Zhang, W.Y., and Kong, L.D. (2009) Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 33(3), 435-449.
46. Webster, H.H., Flores, G., Marcotte, E.R., Cecyre, D., Quirion, R., and Srivastava, L.K. (2000) Olfactory bulbectomy alters NMDA receptor levels in the rat prefrontal cortex. Synapse 37, 159-162.
47. Gupta, A., Vij, G., Sharma, S., Tirkey, N., Rishi, P., and Chopra, K. (2009) Curcumin, a polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model. Immunobiology 214, 33-39.